𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis

✍ Scribed by Mohammed A. Sharawey; Eglal M. Shawky; Lamia H. Ali; Ahmed Ali Mohammed; Hatem A. Hassan; Yasser M. Fouad

Book ID
107593957
Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
253 KB
Volume
5
Category
Article
ISSN
1936-0533

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Predictors of response to therapy with t
Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome
✍ AndrΓ© Nazar; Gustavo Henrique Pereira; MΓ³nica Guevara; Marta MartΓ­n-Llahi; Marie πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 169 KB πŸ‘ 1 views

Terlipressin plus albumin is an effective treatment for type 1 hepatorenal syndrome (HRS), but approximately only half of the patients respond to this therapy. The aim of this study was to assess predictive factors of response to treatment with terlipressin and albumin in patients with type 1 HRS. T